Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT00098332
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed cutaneous T-cell lymphoma
* Refractory to prior treatment
* Stage IIA, IIB, III, IVA, or IVB disease
* Measurable disease
PATIENT CHARACTERISTICS:
Age
* 18 and over
Performance status
* ECOG 0-2
Life expectancy
* At least 3 months
Hematopoietic
* Not specified
Hepatic
* AST and/or ALT ≤ 3 times upper limit of normal
* Hepatitis B and/or hepatitis C negative
Renal
* Creatinine clearance ≥ 40 mL/min
Immunologic
* Human T-cell lymphotrophic virus type I (HTLV-I) negative
* HIV negative
* No active serious infection not controlled by antibiotics
Other
* Not pregnant or nursing
* Negative pregnancy test
* Fertile patients must use effective contraception
* No known impaired absorption of the gastrointestinal tract
* No other illness that would preclude study participation
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* More than 21 days since prior chemotherapy and recovered
Endocrine therapy
* Concurrent topical corticosteroids allowed provided patient remains on a stable dose
Radiotherapy
* No concurrent radiotherapy
Surgery
* Not specified
Other
* More than 30 days since prior investigational agents and recovered
* No concurrent tanning bed use
* No other concurrent therapy for cutaneous T-cell lymphoma
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00098332
Study Brief:
Protocol Section:
NCT00098332